Taro Pharmaceutical Industries Ltd (NYSE:TARO)
| 38.00 Delayed Data As of 3:59pm ET |  +0.01 / +0.03%Today’s Change | 22.89 Today|||52-Week Range 42.22 | +30.85% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Assets | Cash | 576.8M | 600.4M | 576.6M | 567.5M | |
| Short Term Investment Cash | 94.9M | 23.6M | -23.8M | -9.1M | ||
| Cash & Short Term Investments | 1.2B | 1.4B | 1.4B | 1.0B | ||
| Receivables | Receivables | 283.6M | 325.9M | 320.0M | 276.6M | |
| Inventories | Inventories | 141.7M | 144.5M | 146.1M | 149.1M | |
| Current Assets | Prepaid Expenses | 9.8M | 8.8M | 6.3M | 7.1M | |
| Other Current Assets | 213.9M | 133.1M | 1.7M | 556.0K | ||
| Current Assets | 1.9B | 2.0B | 1.9B | 1.5B | ||
| Total Assets | Property, Plant and Equipment - Gross | 376.6M | 398.1M | 427.5M | 442.7M | |
| Depreciation | -217.1M | -218.0M | -233.8M | -236.5M | ||
| Intangible Assets | 15.5M | 13.1M | 14.3M | 16.0M | ||
| Other Assets | 31.8M | 29.6M | 30.0M | 31.1M | ||
| Total Assets | 2.2B | 2.3B | 2.4B | 2.1B | ||
| Liabilities | Accounts Payable | 18.9M | 16.4M | 25.7M | 35.1M | |
| Accrued Expenses | 17.2M | 14.6M | 18.0M | 16.3M | ||
| Other Current Liabilities | 183.7M | 156.0M | 150.3M | 143.8M | ||
| Other Liabilities | 245.5M | 209.8M | 215.8M | 216.8M | ||
| Total Liabilities | Deferred Taxes | -1.8M | -8.2M | -84.0M | -108.0M | |
| Other Liabilities | 27.0K | 6.0K | 297.0K | 1.5M | ||
| Total Liabilities | 250.9M | 215.9M | 222.8M | 224.2M | ||
| Equity | Minority Interest | -339.0K | -310.0K | -1.1M | -345.0K | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 1.9B | 2.1B | 2.2B | 1.9B | ||
| Total Shareholder Equity | 1.9B | 2.1B | 2.2B | 1.9B | ||
| Share Information | Common Shares Outstanding | 42.8M | 40.5M | 39.4M | 38.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
